New check hope for breast cancer
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.THOUSANDS OF women who have had breast cancer could have a better quality of life if a new test is introduced, scientists said yesterday.
At present, all post-menopausal, breast-cancer patients are given aggressive drug and chemotherapy treatments because the standard test only detects recurrences in 7 per cent of cases. The new test - in which cells taken from the lymph nodes are stained with a substance that triggers an immune response - can identify tumours in 20 per cent of cases.
The hope is that women cleared by the new test will be able to safely skip the treatments, with their unpleasant side effects.
The new research, by a team led by Professor Munro Neville of the Ludwig Institute for Cancer Research, will be published in The Lancet tomorrow.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments